Literature DB >> 30681520

Measurement of Corneal Biomechanical Properties in Diabetes Mellitus Using the Ocular Response Analyzer and the Corvis ST.

Lisa Ramm1, Robert Herber, Eberhard Spoerl, Lutz E Pillunat, Naim Terai.   

Abstract

PURPOSE: Hyperglycemia in diabetes mellitus (DM) might induce changes in corneal biomechanics. Therefore, biomechanical properties of the cornea were measured using the ocular response analyzer and the Corvis ST.
METHODS: In the study, 35 eyes of 35 diabetic patients were included. After an ophthalmological examination, measurements with the ocular response analyzer and the Corvis ST were taken. Additionally, biometry and corneal topography were performed and HbA1c values were collected. Results were compared to an age-, pachymetry- and intraocular pressure-matched group of 35 healthy subjects.
RESULTS: Mean age (67.6 ± 10.3; 64.1 ± 8.3 years), intraocular pressure (13.4 ± 2.9; 12.8 ± 2.8 mm Hg), and central corneal thickness (556.4 ± 31.7; 548.6 ± 32.9 μm) were not significantly different between the groups (P > 0.05). In DM, the corneal hysteresis (CH) and the corneal resistance factor (CRF) were increased (CH: 10.8 ± 2 vs. 9.4 ± 1.6, P = 0.002; CRF: 10.6 ± 2.1 vs. 9.6 ± 1.5, P = 0.022). Also, most dynamic corneal response parameters showed significant differences. Beside others, A1 and A2 deflection amplitudes were increased (P < 0.001) and highest concavity and A2 time were extended (P < 0.001 and 0.007) in DM. According to current HbA1c value, DM was classified as controlled (≤7%) and poorly controlled (>7%) and significant biomechanical differences were measured between both groups.
CONCLUSIONS: In DM, significant changes in corneal biomechanical properties were detectable. In patients, CH and CRF were increased and most dynamic corneal response parameters were different compared to healthy subjects.

Entities:  

Mesh:

Year:  2019        PMID: 30681520     DOI: 10.1097/ICO.0000000000001879

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Assessment of corneal topographic, tomographic, densitometric, and biomechanical properties of Fabry patients with ocular manifestations.

Authors:  Veysel Cankurtaran; Kemal Tekin; Ayse Idil Cakmak; Merve Inanc; Faruk Hilmi Turgut
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-08       Impact factor: 3.117

Review 2.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

Review 3.  Advances in Biomechanical Parameters for Screening of Refractive Surgery Candidates: A Review of the Literature, Part III.

Authors:  Majid Moshirfar; Mahsaw N Motlagh; Michael S Murri; Hamed Momeni-Moghaddam; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019

Review 4.  Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus.

Authors:  Tina B McKay; Shrestha Priyadarsini; Dimitrios Karamichos
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600

5.  A clinical method for estimating the modulus of elasticity of the human cornea in vivo.

Authors:  David C Pye
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

Review 6.  Corneal Biomechanical Assessment with Ultra-High-Speed Scheimpflug Imaging During Non-Contact Tonometry: A Prospective Review.

Authors:  Pedro Manuel Baptista; Renato Ambrosio; Luis Oliveira; Pedro Meneres; Joao Melo Beirao
Journal:  Clin Ophthalmol       Date:  2021-04-06

Review 7.  Biomechanical analysis of ocular diseases and its in vitro study methods.

Authors:  Yali Zhao; Guohuang Hu; Yuwei Yan; Zhen Wang; Xiaohua Liu; Huanhuan Shi
Journal:  Biomed Eng Online       Date:  2022-07-23       Impact factor: 3.903

8.  Changes in corneal biomechanics in patients with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Xiaoyi Wang; Guihua Xu; Wei Wang; Juanjuan Wang; Lili Chen; Mingguang He; Zilin Chen
Journal:  Acta Diabetol       Date:  2020-03-22       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.